Review Test Submission: Week 1 - Quiz
Content
User Roan Forgie
Course NURS-6521N-22,Advanced Pharmacology.2018 Fall Quarter 08/27-11/18-
PT27
Test Week 1 - Quiz
Started 9/1/18 6:01 PM
Submitted 9/1/18 7:38 PM
Due Date 9/3/18 1:59 AM
Status Completed
Attempt Score 38 out of 40 points 2
Time Elapsed 1 hour, 36 minutes out of 1 hour and 40 minutes
Instructions Please answer each question below and click Submit when you have
completed the Quiz.
Results
Displayed
Feedback
Question 1
1 out of 1 points
A patient has been receiving regular doses of an agonist for 2 weeks. Which of the following
should the nurse anticipate?
Response
Feedback:
Receptors are not static; they can change or modify their response to a
stimulus. Such change occurs when a receptor is continuously stimulated to act
or continually inhibited from action. Continual stimulation from an agonist
usually makes the receptor desensitized to the drug and thus less active.
Therefore, the nurse should anticipate a decrease in effectiveness of the drug.
Question 2
1 out of 1 points
A nurse is discussing with a patient the efficacy of a drug that his physician has suggested,
and he begin taking. Efficacy of a drug means which of the following?
Response
Feedback:
Efficacy indicates how well a drug produces its desired effect. Different drugs
have different strengths of attraction or affinity for receptor sites. A drug's
ability to stimulate its receptor is called its intrinsic activity, and the amount of
a drug that must be given to produce a particular response is called the potency
of a drug.
Question 3
1 out of 1 points
An older adult patient with a history of Alzheimer's disease and numerous chronic health
problems has been prescribed several medications during his current admission to hospital
and recent declines in the patient's cognition have impaired his ability to swallow pills. Which
of the following medications may the nurse crush before administering them to this patient?
Response
Feedback:
A tablet that is designed for immediate release into the gastric environment is
normally safe to crush and administer to the patient. Enteric coated and
sustained release tablets may not be crushed because doing so compromising
